CREDIT SUISSE AG/ - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2021$21,000
-86.4%
12,076
-83.1%
0.00%
Q3 2021$154,000
-36.1%
71,468
+3.8%
0.00%
Q2 2021$241,000
-64.3%
68,860
+0.6%
0.00%
Q1 2021$675,000
-32.7%
68,455
-26.0%
0.00%
Q4 2020$1,003,000
-40.1%
92,492
-43.1%
0.00%
-100.0%
Q3 2020$1,674,000
-19.1%
162,438
+63.9%
0.00%0.0%
Q2 2020$2,070,000
+314.0%
99,110
+93.9%
0.00%
Q1 2020$500,000
-52.8%
51,119
-44.4%
0.00%
-100.0%
Q4 2019$1,060,000
+1506.1%
91,947
+653.8%
0.00%
Q3 2019$66,000
-53.8%
12,197
+1.6%
0.00%
Q2 2019$143,000
+120.0%
12,009
-3.6%
0.00%
Q1 2019$65,000
+58.5%
12,458
-4.0%
0.00%
Q4 2018$41,000
-50.0%
12,974
-16.7%
0.00%
Q2 2018$82,000
+134.3%
15,568
+29.9%
0.00%
Q4 2016$35,000
-41.7%
11,982
-18.2%
0.00%
Q3 2016$60,000
-61.8%
14,647
-70.5%
0.00%
Q2 2016$157,00049,6960.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders